2022 AADOCR/CADR Annunal Meeting
The 51st Annual Meeting of the AADOCR was held in conjunction with the 46th Annual Meeting of the Canadian Association for Dental Research, from March 14-26 as a hybrid experience with 839 individuals from 18 countries attending in person in Atlanta, GA and 692 individuals from 21 countries attending virtually.The recordings in this library from the meeting are a selection of the science that was to be presented as part of the Annual Meeting. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers and symposia from a collection of scientific groups and networks.
This session can be purchased as part of the full meeting recordings within the product bundles
The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Session Description
The current market of clinical protocols and medical devices, including medications such as opioids, require the appropriate stop and check of characterization of clinical toxicity calling for time sensitive intervention and even more so real time characterization of pathosis and subsequent toxicity of interventional options and selections.
The symposium will reference an example model the current literature on the opioid crisis and policy intersect, together with historic and concurrent science on how the use of laser and photonic devices show potentiated integration with respective indication of their healing and pain control capacity while simultaneously mitigate the opioid addiction crisis, and further serve as a translational adaptation in other disciplines. [1]
Further, clinical toxicology of pathophysiological process of disease, in addition to characterization of other endogenous and/ or exogenous variables, will affect and render various summaries of clinical potential output. “Private health is public health”[2] and whilst outlining the sequential variables and phases between the two, it is crucial to highlight effective and limited-liability protocols of clinical treatment and technological devices, and selectively identify the preferred qualifiable and quantifiable low toxicity index options when considering innovation. Laser and optical physics will be presented as the obvious innovative track with both therapeutic and toxicity indexes presented and compared when considering clinical protocols in the management of pain and pathophysiological process of disease.
Learning Objectives
March 26, 2022
Presenters
Claudia Cotca - Threshold Clinical Toxicity & Characterization in Clinical Protocols & Medical Devices
Sonia Regina Bordin-Aykroyd - Lasers and Optical Devices in Healing and Pain Control
Georgios Romanos - Lasers in Implant and Periodontics
Sponsoring Groups/Networks
Pharmacology/Therapeutics/Toxicology
CE Credits
1.5 Contact Hours
Financial Interest Disclosure:
None
The current market of clinical protocols and medical devices, including medications such as opioids, require the appropriate stop and check of characterization of clinical toxicity calling for time sensitive intervention and even more so real time characterization of pathosis and subsequent toxicity of interventional options and selections.
The symposium will reference an example model the current literature on the opioid crisis and policy intersect, together with historic and concurrent science on how the use of laser and photonic devices show potentiated integration with respective indication of their healing and pain control capacity while simultaneously mitigate the opioid addiction crisis, and further serve as a translational adaptation in other disciplines. [1]
Further, clinical toxicology of pathophysiological process of disease, in addition to characterization of other endogenous and/ or exogenous variables, will affect and render various summaries of clinical potential output. “Private health is public health”[2] and whilst outlining the sequential variables and phases between the two, it is crucial to highlight effective and limited-liability protocols of clinical treatment and technological devices, and selectively identify the preferred qualifiable and quantifiable low toxicity index options when considering innovation. Laser and optical physics will be presented as the obvious innovative track with both therapeutic and toxicity indexes presented and compared when considering clinical protocols in the management of pain and pathophysiological process of disease.
Learning Objectives
- Participants will be informed on the value of integrating therapeutic and toxicity indexes during patient evaluation, to assess the potential outcome, before defining their clinical protocols, the utilization of medical devices, or prescription of pharmacotherapy.
- Participants will understand how and why lasers can increase the speed and quality of healing, controlling pain and greatly reducing the need for prescription of pharmacological substances, thereby helping to mitigate the opioid crisis.
- Participants will understand the Optical-Biological Tissue Interaction mechanisms involved in the clinical use of photonic devices. Participants will have the opportunity to see some clinical applications of such devices and get a further understanding of working with them.
March 26, 2022
Presenters
Claudia Cotca - Threshold Clinical Toxicity & Characterization in Clinical Protocols & Medical Devices
Sonia Regina Bordin-Aykroyd - Lasers and Optical Devices in Healing and Pain Control
Georgios Romanos - Lasers in Implant and Periodontics
Sponsoring Groups/Networks
Pharmacology/Therapeutics/Toxicology
CE Credits
1.5 Contact Hours
None
Not eligible for individual purchase must purchase as part of a meeting bundle.
